Shanta P. Boddapati, Ph.D.
Affiliations: | 2011 | Chemical Engineering | Arizona State University, Tempe, AZ, United States |
Area:
Biomedical Engineering, Molecular Biology, Neuroscience BiologyGoogle:
"Shanta Boddapati"Parents
Sign in to add mentor| Michael Sierks | grad student | 2011 | Arizona State | |
| (Antibody Based Therapeutics for Alzheimer's Disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yang G, Velgos SN, Boddapati SP, et al. (2014) Probing antibody-antigen interactions Microbiology Spectrum. 2: 1-13 |
| Kasturirangan S, Reasoner T, Schulz P, et al. (2013) Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. Biotechnology Progress. 29: 463-71 |
| Boddapati S, Levites Y, Suryadi V, et al. (2012) Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPP. Journal of Alzheimer's Disease : Jad. 28: 961-9 |
| Kasturirangan S, Li L, Emadi S, et al. (2012) Nanobody specific for oligomeric β-amyloid stabilizes nontoxic form. Neurobiology of Aging. 33: 1320-8 |
| Boddapati S, Levites Y, Sierks MR. (2011) Inhibiting β-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP. Journal of Molecular Biology. 405: 436-47 |
| Wang MS, Boddapati S, Emadi S, et al. (2010) Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. Bmc Neuroscience. 11: 57 |
| Kasturirangan S, Boddapati S, Sierks MR. (2010) Engineered proteolytic nanobodies reduce Abeta burden and ameliorate Abeta-induced cytotoxicity. Biochemistry. 49: 4501-8 |
| Wang MS, Boddapati S, Sierks MR. (2010) Antifibrillizing agents catalyze the formation of unstable intermediate aggregates of beta-amyloid. Biotechnology Progress. 26: 1172-9 |
| Wang M, Boddapati S, Sierks M. (2009) Response letter to comments on "Cyclodextrins promote protein aggregation posing risks for therapeutic applications". Biochemical and Biophysical Research Communications. 390: 1426-7 |
| Wang MS, Boddapati S, Sierks MR. (2009) Cyclodextrins promote protein aggregation posing risks for therapeutic applications. Biochemical and Biophysical Research Communications. 386: 526-31 |